NANG KUANG PHARMACEUTICAL CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 44.55 TWD | -0.11% |
|
+1.02% | -16.42% |
| Sales 2022 | 1.94B 59.56M 4.76B | Sales 2023 | 2.15B 66M 5.28B | Capitalization | 5.38B 165M 13.21B |
|---|---|---|---|---|---|
| Net income 2022 | 352M 10.8M 864M | Net income 2023 | 198M 6.08M 486M | EV / Sales 2022 | 3.33 x |
| Net Debt 2022 | 6.62M 203K 16.26M | Net Debt 2023 | 327M 10.04M 803M | EV / Sales 2023 | 2.66 x |
| P/E ratio 2022 |
18.4
x | P/E ratio 2023 |
27.2
x | Employees | 552 |
| Yield 2022 |
3.6% | Yield 2023 |
3.75% | Free-Float | 44.45% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.11% | ||
| 1 week | +1.02% | ||
| Current month | -5.11% | ||
| 1 month | -3.78% | ||
| 3 months | -8.90% | ||
| 6 months | -15.30% | ||
| Current year | -16.42% |
1 week
44.10
45.20
1 month
43.8547.70
Current year
43.8554.30
1 year
43.8585.70
3 years
32.6085.70
5 years
28.8085.70
10 years
28.1385.70
| Managers | Title | Age | Since |
|---|---|---|---|
Yue Pei Wang
CEO | Chief Executive Officer | - | 31/08/02 |
Wen Yung Tsai
DFI | Director of Finance/CFO | - | 31/07/10 |
Li Hsien Chen
CHM | Chairman | - | 09/07/05 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Chao Chin Wang
BRD | Director/Board Member | - | 24/06/14 |
Li Hsien Chen
CHM | Chairman | - | 09/07/05 |
Yue Pei Wang
CEO | Chief Executive Officer | - | 31/08/02 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/04/24 | 44.55 | -0.11% | 111,210 |
| 25/04/24 | 44.6 | -0.67% | 54,859 |
| 24/04/24 | 44.9 | +0.45% | 72,475 |
| 23/04/24 | 44.7 | +1.25% | 128,379 |
| 22/04/24 | 44.15 | +0.11% | 171,203 |
End-of-day quote Taiwan S.E., April 25, 2024
More quotes
NANG KUANG PHARMACEUTICAL CO., LTD. is principally engaged in the manufacture, processing and trading of western medicine. The company main products include injections, sterile injections, powder injections, hard capsules, bare ingots, film ingots, casing ingots, granules and creams, among others. The Company is also engaged in the manufacture, processing and trading of medical equipment. The Company distributes its products within the domestic market and to overseas markets.
Sector
Pharmaceuticals
Calendar
17/06/2024
- Annual General Meeting
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.42% | 138M | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- 1752 Stock
